Novartis Eyes Gene Therapy Growth With Vedere Acquisition

Paying $150m Upfront

 
• By Kevin Grogan
  
Eye in an high tech environment
Novartis expanding eye gene therapy presence • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies